Image
Recommendation
Scalp cooling and chemotherapy
Consider scalp cooling to reduce the risk of hair loss for patients receiving chemotherapy, noting scalp cooling may be less effective with anthracycline-containing regimens.
Consider scalp cooling to reduce incidence of chemotherapy-induced alopecia for patients receiving chemotherapy. Results may be less effective with anthracycline-containing regimens (Based upon lower level evidence)
Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate
How this guidance was developed
This recommendation was adopted from the NCCN 2019 guidelines (US). The source recommendation was based on a systematic review of the evidence conducted in June 2015 and was graded ‘2A’ (using NCCN methods) by the source guideline authors. The source recommendation was accepted with minor stylistic changes such as changing ‘alopecia’ to ‘hair loss’, but with no changes to the meaning or tone of the source recommendation.
Scalp cooling and chemotherapy
Recommendation
Consider scalp cooling to reduce the risk of hair loss for patients receiving chemotherapy, noting scalp cooling may be less effective with anthracycline-containing regimens.
Principles in action
Supportive care
This recommendation was adopted from the NCCN 2019 guidelines (US). The source recommendation was based on a systematic review of the evidence conducted in June 2015 and was graded ‘2A’ (using NCCN methods) by the source guideline authors. The source recommendation was accepted with minor stylistic changes such as changing ‘alopecia’ to ‘hair loss’, but with no changes to the meaning or tone of the source recommendation.